Cleared Traditional

K902786 - MILENIA (TM) LH

K902786 is the FDA 510(k) clearance for MILENIA (TM) LH by Diagnostic Products Corp.. It is a Class 1 Chemistry device (product code CEP) cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K902786 · Diagnostic Products Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1990
Decision
108d
Days
Class 1
Risk

K902786 is an FDA 510(k) clearance for the MILENIA (TM) LH. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on October 12, 1990 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K902786 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 1990
Decision Date October 12, 1990
Days to Decision 108 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 88d · This submission: 108d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CEP Radioimmunoassay, Luteinizing Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1485
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEP Radioimmunoassay, Luteinizing Hormone

All 58
Devices cleared under the same product code (CEP) and FDA review panel - the closest regulatory comparables to K902786.
COBAS CORE LH EIA
K930306 · Roche Diagnostic Systems, Inc. · May 1993
LH GEN III SELF-TEST/CONCEIVE
K920160 · Quidel Corp. · Mar 1992
CIBA CORNING ACS LH IMMUNOASSAY
K910198 · Ciba Corning Diagnostics Corp. · Feb 1991
CIBA CORNING MAGIC LITE LH IMMUNOASSAY
K902398 · Ciba Corning Diagnostics Corp. · Jun 1990
ENZYMUN TEST(R) LH
K900779 · Boehringer Mannheim Corp. · Apr 1990
TANDEM-E LH IMMUNOENZYMETRIC ASSAY KIT
K895094 · Hybritech, Inc. · Oct 1989